PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 2026Molecules0 citationsOpen Access

Immunoconjugated Magnetic Graphene for Exosome Capture in SARS-CoV-2 Pseudovirus-Infected Cells

RPRosamaria PennisiGNGiulia NeriPTPaola Trischitta

Key Points

  • This research aims to develop a method for the selective isolation of exosomes from SARS-CoV-2 pseudovirus-infected cells using graphene-based magnetic units.
  • Engineered graphene-based magnetic units (MAGU) for exosome capture
  • Used ultracentrifugation to enrich total extracellular vesicles
  • Conducted immunomagnetic capture using anti-CD9 antibody
  • Transduced 293T cells with SARS-CoV-2 spike pseudovirus for viral simulation
  • Successfully isolated CD9-positive exosomes using MAGU-anti-CD9
  • Identified enrichment of CD147 in isolated exosomes, linked to SARS-CoV-2 entry
  • Demonstrated selective isolation performance with comprehensive molecular profiling of exosome subpopulations

Abstract

Graphene-based nanomaterials exhibit exceptional physicochemical properties that facilitate a range of diverse biomedical applications, including liquid biopsy. In this study, graphene-based magnetic units, termed MAGU (MAGnetic Units), were specifically engineered for the selective isolation of exosomes. Total extracellular vesicles were first enriched using ultracentrifugation, followed by immunomagnetic capture of CD9+ exosomes. MAGU functionalized with anti-CD9 antibody (MAGU-anti-CD9) efficiently recovered a CD9-positive exosome subpopulation expressing canonical markers ALIX, CD147, TSG101, and Flotillin-1, thereby confirming selective isolation performance. To investigate viral associated signaling, 293T cells were transduced with SARS-CoV-2 spike pseudovirus. This pseudovirus was engineered to express the SARS-CoV-2 spike protein, enabling simulation of viral entry and assessment of potential alterations in the exosomal profile induced by viral binding. Exosomes released by pseudovirus-transduced 293T cells were analyzed and compared to those from non-transduced controls. The MAGU-anti-CD9 complex selectively isolated a defined subset of CD9-positive vesicles enriched in the multifunctional transmembrane glycoprotein CD147, which has been proposed as a cofactor in SARS-CoV-2 entry. Comprehensive molecular profiling of selectively captured exosome subpopulations is expected to further support the application of MAGU technology in virus–host interaction research and liquid-biopsy-based diagnostics.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pennisi et al. (2026) studied this question.

synapsesocial.com/papers/698d6e055be6419ac0d53673https://doi.org/10.3390/molecules31040612
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Magnetically-Enhanced Electrochemical ELISA for the Detection of Sars-Cov-2 Nucleoprotein2024
  2. 2Improvements of magnetic nanoparticle assays for SARS-CoV-2 detection using a mimic virus approach2024 · 7 citations
  3. 3SARS-CoV-2 inhibition through mRNA delivery using engineered extracellular vesicles displaying the spike protein2025 · 4 citations
  4. 4A functionally tunable magnetic nanochains platform for N-glycoproteomic analysis of extracellular vesicles from ultratrace biofluids2025 · 7 citations
  5. 5Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry2025